Active-ingredient Dossier
Hydroxychloroquine Sulfate
Active-ingredient Dossier for Hydroxychloroquine Sulfate (antimalarial agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: APO-HYDROXYCHLOROQUINE
- Brand: HYDROXYCHLOROQUINE
- Brand: IPCA-HYDROXYCHLOROQUINE
- Brand: HYDROXYCHLOROQUINE-WGR
- Therapeutic area: Immunology
- Therapeutic area: ["Immunology","Infectious Disease"]
What is
Hydroxychloroquine Sulfate Hydroxychloroquine Sulfate is an antimalarial agent.
Australian brands containing
Hydroxychloroquine Sulfate — HEQUINEL — PLAQUENIL — APO-HYDROXYCHLOROQUINE — HYDROXYCHLOROQUINE — IPCA-HYDROXYCHLOROQUINE — HYDROXYCHLOROQUINE-WGR
Therapeutic areas
Hydroxychloroquine Sulfate is registered in Infectious Disease (5 brands) and Immunology (1 brand).
Sponsor landscape
The ingredient is marketed by five sponsors: Arrotex Pharmaceuticals, Generic Health, GM Pharma, Ipca Pharma, and Sanofi-Aventis.
PBS and regulatory activity
One brand containing hydroxychloroquine sulfate has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 December 2025.